STAT+: Tracking the FDA expert review of Replimune’s melanoma treatment

Thursday, July 30, 2026 · matthew herper; elaine chen

Source Summary

STAT is live-blogging a meeting of FDA experts to review Replimune’s experimental melanoma drug, RP1.